Biogen (BIIB) Notes Payables (2009 - 2025)
Biogen (BIIB) posted quarterly Notes Payables of $1.7 billion for Q1 2025, up 599.64% year-over-year from $250.0 million in Q1 2024, and little changed quarter-over-quarter from $1.7 billion in Q4 2024.
Biogen (BIIB) Notes Payables (2009 - 2025) Analysis & Trends
Biogen's Notes Payables history runs 12 years deep, the most recent figure standing at $1.7 billion for Q1 2025.
- In Q1 2025, Notes Payables rose 599.64% year-over-year to $1.7 billion; the TTM figure through Mar 2025 stood at $1.7 billion (up 599.64% YoY), while the FY2024 annual figure was $1.7 billion, up 1065.73% from the prior year.
- Notes Payables for Q1 2025 stood at $1.7 billion, roughly flat from $1.7 billion in the prior quarter.
- The five-year high for Notes Payables was $1.7 billion in Q1 2025, with the low at $150.0 million in Q4 2023.
- The 5-year median for Notes Payables is $999.3 million (2021), against an average of $1.0 billion.
- Peak annual rise in Notes Payables reached 1065.73% in 2024, while the deepest fall reached 249.62% in 2024.
- Biogen's Notes Payables stood at $999.1 million in 2021, then gained by 0.07% to $999.8 million in 2022, then tumbled by 85.0% to $150.0 million in 2023, then soared by 1065.73% to $1.7 billion in 2024, then grew by 0.03% to $1.7 billion in 2025.
- Business Quant data shows BIIB's Notes Payables at $1.7 billion in Q1 2025, $1.7 billion in Q4 2024, and $1.7 billion in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Biogen | 32.04 Bn | 30.76 Bn | 1.96 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 1.75 Bn |
| Dec 31, 2024 | 1.75 Bn |
| Sep 30, 2024 | 1.75 Bn |
| Mar 31, 2024 | 250.00 Mn |
| Dec 31, 2023 | 150.00 Mn |
| Sep 30, 2023 | 500.00 Mn |
| Jun 30, 2022 | 999.80 Mn |
| Mar 31, 2022 | 999.50 Mn |
| Dec 31, 2021 | 999.10 Mn |
| Sep 30, 2021 | 998.80 Mn |
| Mar 31, 2020 | 1.50 Bn |
| Dec 31, 2019 | 1.50 Bn |
| Sep 30, 2019 | 1.50 Bn |
| Mar 31, 2013 | 203.32 Mn |
| Dec 31, 2012 | 453.38 Mn |
| Sep 30, 2012 | 453.21 Mn |
| Jun 30, 2012 | 453.05 Mn |
| Mar 31, 2012 | 453.36 Mn |
| Dec 31, 2011 | 3.29 Mn |
| Sep 30, 2011 | 3.42 Mn |